TSO3
Çan
About TSO3
TSO3 develops innovative low temperature sterile reprocessing solutions for medical devices. Through superior and innovative low-temperature sterile reprocessing solutions for medical devices, we offer sterility and economic efficiency. This means better and more accessible medical care.Founded in 1998, TSO3 originally developed a unique sterilization process based on only ozone as the sterilizing agent. It offered major savings over competing low-temperature sterilization methods, greater safety for both users and patients, and was considered a “green” technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $20.1M
- Funding stage: IPO
- Last round: Post-IPO Debt (Aug 2018)
- Ticker: tsx:TOS
- Website: tso3.com
- Phone: 1(418)651-0003
Industries & Categories
Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/tso3-2242574 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.